Literature DB >> 24680419

Immune thrombocytopenic purpura: major progress in knowledge of the pathophysiology and the therapeutic strategy, but still a lot of issues.

Bertrand Godeau1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24680419     DOI： 10.1016/j.lpm.2014.02.010

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0755-4982            Impact factor:   1.228


× No keyword cloud information.
  4 in total

1.  Comparative of three methods (ELIZA, MAIPA and flow cytometry) to determine anti-platelet antibody in children with ITP.

Authors:  Mohsen Hamidpour; Ghader Khalili; Nader Tajic; Bi Bi Shahin Shamsian; Rafie Hamidpour
Journal:  Am J Blood Res       Date:  2014-12-15

2.  Clinical Practice Updates in the Management Of Immune Thrombocytopenia.

Authors:  Ayesha M Khan; Halina Mydra; Ana Nevarez
Journal:  P T       Date:  2017-12

3.  Association of CD4(+)CD25(+)FoxP3(+) regulatory T cells with natural course of childhood chronic immune thrombocytopenic purpura.

Authors:  Bo Ra Son; Ji Yoon Kim
Journal:  Korean J Pediatr       Date:  2015-05-22

4.  Immune thrombocytopenic purpura caused by the over-the-counter weight supplement Root of Tejocote (Crataegus species).

Authors:  Hussam Alhasson; Eugene Muchnik
Journal:  Clin Case Rep       Date:  2020-03-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.